UVic Genome BC Proteomics Centre Receives Funding for First Step in Designing Drugs to Treat Prion and Prion-Like Diseases

The UVic Genome BC Proteomics Centre has received funding from PrioNet Canada for research into designing drugs to treat Prion and Prion-like diseases.

"Dr. Christoph Borchers, Director of the University of Victoria-Genome BC Proteomics Centre, is collaborating with researchers from the University of Alberta and University of Western Ontario to characterize the changes that occur to the three-dimensional structure of prion fibrils (small, nerve-like fibers) as well as the molecular mechanisms that lead to those changes. Using a combination of protein chemistry and mass spectrometry, he is working to explain what occurs when a ‘good’ prion protein changes to a ‘bad’ one during disease development."

The official press release can be viewed here